Product analysis
Circulari-T Blood combines circulation-focused plant ingredients, with ginkgo providing limited support for attention. The ginkgo preparation is not identified closely enough to predict dependable everyday focus benefits.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality57
Chromium has a favorable identified form, while the plant preparations have less certain quality. Some named plant compounds do not establish how closely the extracts match well-defined preparations.
Ingredient Transparency73
All amounts and most forms are disclosed, giving a useful picture of the serving. Capsicum and buckwheat lack form details, and ginkgo blend proportions are omitted.
Value For Money31
The chromium portion is expensive for the amount supplied. The other ingredients lack enough value information to support a confident conclusion about the whole blend.
Customer Satisfaction70
Customer feedback is positive across a few hundred reviews. The moderate review history gives a useful but limited picture of satisfaction.
Product Focus52
Ginkgo accounts for most of the limited support for attention and cognition. The other plant ingredients do not establish a reliable improvement in everyday concentration or productivity.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.99
- Customer rating
- 4.5 · 270 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Chromium (Chromium Niacinate) | 200 mcg | |
Horse Chestnut (Aescin) | 250 mg | |
Butcher's Broom root extract (Ruscogenins) | 200 mg | |
Grape seed extract (Procyanodolic value) | 200 mg | |
Gotu Kola aerial extract (Triterpenes) | 200 mg | |
Cayenne | 200 mg | |
Ginkgo leaf extract (Flavone Glycosides, Terpene Lactones) | 120 mg | |
Buckwheat | 100 mg | |
Citrus Bioflavonoids (Flavones) | 50 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
Chromium Chemical Form
Branded & Trademarked Sources
Dose, Safety & Label Transparency85
Elemental Chromium Dosage
Label Transparency & Disclosure
Value10
Price per 200 mcg Chromium
How this ingredient is rated
Composition and Label Disclosure70
Marker and Preparation Disclosure
Declared Ginkgolic Acid Limit
Composition and Label Disclosure100
Individual Preparation Amount Disclosure
Commercial Price and Usability
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
- Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
- Ginkgo biloba in the Aging Process: A Narrative Review.
- Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
- Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
- A Comprehensive insight into the effect of chromium supplementation on oxidative stress indices in diabetes mellitus: A systematic review.
- Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis.
- [Chromium supplementation in patients with type 2 diabetes and high risk of type 2 diabetes: a meta-analysis of randomized controlled trials].
- [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].